Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $749M (up 62.0% year over year) with net income of $27M.
Q1 2026 key financials · XBRL
- Revenue
- $749M
- +62.0% YoY
- Net income
- $27M
- +2245.5% YoY
- Operating margin
- 3.6%
- EPS (diluted)
- $0.05
Source: XBRL data from the CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Q1 2026 10-Q on SEC EDGAR. USD.
CLOVER HEALTH INVESTMENTS, CORP. /DE Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $749.2M, up 62.0% YoY from $462.3M, driven by membership growth and 4.0-star PPO payments
- Insurance benefits expense ratio 86.5% vs 86.1% YoY; net income $27.3M vs $1.3M loss
- Adjusted EBITDA $40.3M vs $25.8M; adjusted SG&A margin 15.9% vs 18.0%
- Cash, equivalents, and investments $418.2M vs $319.9M; operating cash flow $107.9M vs $16.3M use
- Outlook: liquidity sufficient for next 12 months; potential additional financing needs, regulatory restrictions, and lower investment income headwinds
Risk Factors
- No material risk-factor changes disclosed from the 2025 Form 10-K
- Recurring and new business risks could materially impair financial condition and results
- Risk-factor occurrence could significantly or permanently reduce Class A common stock value
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.